Antigen-specific B-1a antibodies induced byFrancisella tularensisLPS provide long-term protection againstF. tularensisLVS challenge
- 17 March 2009
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (11) , 4343-4348
Abstract
Francisella tularensis(Ft), a Gram-negative intracellular bacterium, is the etiologic agent of tularemia. Infection of mice with FtLive Vaccine Strain (FtLVS) organisms i.p. causes a lethal infection that resembles human tularemia. Here, we show that immunization with as little as 0.1 ngFtLVS lipopolysaccharide (Ft-LPS), but notFtlipid A, generates a rapid antibody response that protects wild-type (WT) mice against lethalFtLVS challenge. Protection is not induced inFt-LPS-immunized B cell-deficient mice (μMT or JhD), malexidmice, or Ig transgenic mice that produce a single IgH (not reactive withFt-LPS). Focusing on the cellular mechanisms that underlie this protective response, we show thatFt-LPS specifically stimulates proliferation of B-1a lymphocytes that bind fluorochrome-labeledFt-LPS and the differentiation of these cells to plasma cells that secrete antibodies specific forFt-LPS. This exclusively B-1a antibody response is equivalent in WT, T-deficient (TCRαβ−/−, TCRγδ−/−), and Toll-like receptor 4 (TLR4)-deficient (TLR4−/−) mice and thus is not dependent on T cells or typical inflammatory processes. Serum antibody levels peak ≈5 days afterFt-LPS immunization and persist at low levels for months. Thus, immunization withFt-LPS activates a rare population of antigen-specific B-1a cells to produce a persistent T-independent antibody response that provides long-term protection against lethalFtLVS infection. These data support the possibility of creating effective, minimally invasive vaccines that can provide effective protection against pathogen invasion.Keywords
This publication has 33 references indexed in Scilit:
- Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensisVaccine, 2008
- B cell–intrinsic TLR signals amplify but are not required for humoral immunityJournal of Experimental Medicine, 2007
- Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell SubsetsPLOS ONE, 2007
- The Structure and Function of Francisella LipopolysaccharideAnnals of the New York Academy of Sciences, 2007
- A Defined O-Antigen Polysaccharide Mutant ofFrancisella tularensisLive Vaccine Strain Has Attenuated Virulence while Retaining Its Protective CapacityInfection and Immunity, 2007
- Division and differentiation of natural antibody-producing cells in mouse spleenProceedings of the National Academy of Sciences, 2007
- Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor SignalingScience, 2006
- Regulation of B1 cell migration by signals through Toll-like receptorsJournal of Experimental Medicine, 2006
- Defective B cell development and function in Btk-deficient miceImmunity, 1995
- Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID MiceScience, 1993